Beijing Aosaikang Pharmaceutical Co., Ltd.
SHZ: 002755.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jingfei Ma
- Employees
- 979
- Headquarters
- Nanjing, China
- IPO year
- 2015
- Market cap
- CN¥16.5B
- Website
- https://www.ask-pharm.com
Loading 002755…
Loading profile data…Frequently asked questions about 002755
What does Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) do?
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in digestive, oncology, antibiotic, and other areas. Beijing Ao...
Where does 002755.SZ trade?
Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002755.SZ in?
Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Beijing Aosaikang Pharmaceutical Co., Ltd.?
Jingfei Ma is the chief executive officer of Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ).
Where is Beijing Aosaikang Pharmaceutical Co., Ltd. headquartered?
Beijing Aosaikang Pharmaceutical Co., Ltd. is headquartered in China.
Does 002755.SZ pay a dividend?
Yes — Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) paid a trailing twelve-month dividend of CNY 0.12 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002755.SZ go public?
Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ) completed its initial public offering in 2015.